Log in to save to my catalogue

CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage

CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9b7514e64c5f429f8af27f9559663d3c

CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage

About this item

Full title

CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2019-01, Vol.10 (1), p.53-11, Article 53

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

CRISPR/Cas9 guided gene-editing is a potential therapeutic tool, however application to neurodegenerative disease models has been limited. Moreover, conventional mutation correction by gene-editing would only be relevant for the small fraction of neurodegenerative cases that are inherited. Here we introduce a CRISPR/Cas9-based strategy in cell and...

Alternative Titles

Full title

CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9b7514e64c5f429f8af27f9559663d3c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9b7514e64c5f429f8af27f9559663d3c

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-018-07971-8

How to access this item